← MyLongPath

SSRIs (class)

MedicationClinical2 reviews
0
Average score out of 5
Based on 2 experience(s)

A class of antidepressants used to treat depressive symptoms, anxiety, and certain neurological disorders associated with Long COVID by regulating serotonin levels.

Information
Subcategory
Selective serotonin reuptake inhibitor
Evidence level
4/5
Evidence type
Observational studies and ongoing clinical trials
Treatment class
✓
Score distribution
+5
1 (50%)
+3
0 (0%)
+1
0 (0%)
0
0 (0%)
Negative
1 (50%)
Most improved symptoms
Post-exertional malaise
100%
Practical information
Time to effect
1-2 months
Reported side effects
First week: light headache (50%)All of them (50%)ended up in a hospital (50%)
Latest reviews
M
Anonymous review+5
36-45 y.o. · 5/18/2026

In May 2025 I stopped Citalopram, but long COVID symptoms increased. So I started again October 2025, till now.

M
Anonymous review-5
18-25 y.o. · 4/27/2026
Share your experience

Your feedback helps thousands of people find what really works.

Join the community